Medra

Research on the record

• 2026-06-24Medra launches an AI layer that plans and revises experiments for its robot lab, with a DARPA-funded project to turn written protocols into machine runsLevel 1 · Exists

Graded by how far the evidence went, not how good the result is. See the methodology.

People

Only people the AI4S.fyi record has named: in a round, a timeline entry, commentary, an interview or a sourced role. Not the full team.

Funding rounds tracked

• 2025-12-11Series A · $52MconfirmedLed by Human Capital · With Lux Capital, Neo, NFDG, Catalio Capital Management, Menlo Ventures, 776, Fusion FundStated use: expand the platform, grow teams and deploy with biopharma partners

Each round links to its line on the funding record, with its source.

Also in Autonomous labs on the funding board

The other companies the funding board files under the same field, latest round first. A list of what the record tracks, not a ranking or a market map.

• 2026-10-22Warp SciencesRound (unnamed) · $215MA US chemistry contract research organisation that makes the molecules drug-discovery teams order, starting with variations of a lead compound for lead optimisation. Chemists guide the work while the company automates more of it with AI and robotics and trains models on the data its experiments produce. It says it has no drug pipeline of its own.
• 2026-10-06Multiply LabsSeries B · $75MBuilds robotic clusters that run the manual steps of making cell and gene therapies and other biologics, working with the drugmaker's existing equipment; the drugmakers own and operate the robots.
• 2026-09-21Woshi TechnologyRound (unnamed) · over 100M yuan across several rounds in the past yearA structured chemistry database, AI models for synthesis planning and robotic labs from milligram to kilogram scale, used by chemicals, battery and pharma companies.
• 2026-09-16ChemifySeries B extension · Series B extended to £51.9M ($70M) in totalTurns molecule designs into code that robots run (Chemputation) in automated 'Chemifarm' labs, making small molecules for drug and materials partners.
• 2026-09-16Deep MaterialA+ · nearly 100M yuanDesigns metal alloys with its own models and an automated high-throughput lab, then supplies the materials to 3C, aerospace and fusion customers.
• 2026-09-02RhinovatePre-A · several hundred million yuanPairs an AI-scientist agent with robotic labs and pilot scale-up to develop polymers, carbon-fibre composites and battery electrolytes, incubated at Peking University's Shenzhen campus.

All 14 in this field →